Chemo Pharma Laboratories Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported total income from operations (net) of INR 0.325 million compared with INR 0.227 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 0.127 million against INR 0.100 million a year ago. Net profit from ordinary activities before tax was INR 0.127 million against INR 0.100 million a year ago. Net profit was INR 0.127 million or INR 0.08 per basic and diluted share before and after extraordinary items compared with INR 0.100 million or INR 0.07 per basic and diluted share before and after extraordinary items a year ago.

For the nine months, the company reported total income from operations (net) of INR 2.014 million compared with INR 4.388 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 1.329 million against INR 3.016 million a year ago. Net profit from ordinary activities before tax was INR 1.329 million against INR 3.016 million a year ago. Net profit was INR 1.329 million or INR 1.23 per basic and diluted share before and after extraordinary items compared with INR 3.016 million or INR 0.89 per basic and diluted share before and after extraordinary items a year ago.